APA

Eckert H. G., Badian M. J., Gantz D., Kellner H. M. & Volz M. (19850214). Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man. : Arzneimittel-Forschung.

Chicago

Eckert H G, Badian M J, Gantz D, Kellner H M and Volz M. 19850214. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man. : Arzneimittel-Forschung.

Harvard

Eckert H. G., Badian M. J., Gantz D., Kellner H. M. and Volz M. (19850214). Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man. : Arzneimittel-Forschung.

MLA

Eckert H G, Badian M J, Gantz D, Kellner H M and Volz M. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man. : Arzneimittel-Forschung. 19850214.